Sinarta (glucosamine sulfate) powder for oral solution 1.5 g/3.95 g. sachet №30


Treating symptoms of osteoarthritis, i.e. pain and functional limitation. Nonsteroidal anti-inflammatory and antirheumatic drugs.

Category: Manufacturer: Ukraine


Composition and form of release
Sinart’s drug is produced in the form of a crystalline powder for oral solution, which is odorless, can be either white or almost white, light brown blotches or lumps are possible. The composition of this drug includes the active ingredient glucosamine sulfate 1500 mg and additional substances: aspartame, sorbitol, citric acid, polyethylene glycol.
The cardboard box contains 30 sachets. The weight of one sachet is 3.95 g.
Pharmacological properties
Sinart’s drug belongs to the group of anti-inflammatory drugs that have a positive effect on the musculoskeletal system. The drug has not only anti-inflammatory, but also anti-rheumatic properties, thereby strengthening the bones of the skeleton. The effectiveness of this remedy is noticeable after 2-3 weeks of treatment.
The main component glucosamine sulfate is involved in the construction of bone and cartilage tissue, the synthesis of articular fluid, the creation of tendons, connective skin and tissue. It also helps to reduce degenerative changes in the joints, while improving their mobility and leading to the restoration of cartilaginous surfaces. Sinarta is very well tolerated by patients, but it is contraindicated to use it alone without a doctor’s recommendation.
Sinarta is prescribed and used to treat symptoms of osteoarthritis such as pain and functional limitation.
Sinart’s drug has a number of contraindications for use: a tendency to bleeding, impaired liver and kidney function, phenylketonuria, children under 18 years of age, as well as in cases of individual intolerance to the substances that are part of this drug. Such a component in the composition of the drug as glucosamine is produced from the shell of shellfish, in this case, people who are allergic to shellfish should not use Sinatra.
Application during pregnancy and lactation
It is contraindicated to use Sinarta for women during pregnancy, as well as during breastfeeding.
Method of administration and dosage
Sinarta is intended for direct oral administration.
Before starting treatment, you should consult your doctor.
It is necessary to take the drug during meals, dissolving the contents of one sachet in a glass of water.
The recommended daily dose is 1 sachet (1500 mg glucosamine sulfate). The duration of therapy is 1-3 months, if there is a need, treatment can be repeated 2-3 times a year every 2 months. But it is worth noting that further use and the period of use is agreed with the doctor and is determined individually for each patient, depending on the patient’s condition and medical indications.
There were no cases of overdose in patients taking Sinarta’s drug. In cases of intoxication, side effects may increase.
Side effects
The use of Sinarta can cause negative reactions in the form of: abdominal pain, dyspepsia, flatulence, headache, drowsiness, fatigue and dizziness. Taking the drug can also lead to the development of allergic reactions, erythema, blurred vision, as well as cause itching, angioedema, rash, urticaria, nausea, hair loss, diarrhea or constipation.
Storage conditions and periods
The main conditions for storing Sinarta are: inaccessibility to children, temperature up to + 25 ° C, dry and dark place. The shelf life of this drug is 24 months. Available from pharmacies on prescription.